Author

Eric S. Rogers

Observed names: E. S. Rogers, Eric Rogers

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Observed institutions: Mayo Clinic, Memorial Sloan Kettering Cancer Center, University of Wisconsin–Madison, Emory University, Genentech, University of Rochester Medicine, University of Wisconsin Carbone Cancer Center, Blood Cancer United, University of Rochester

OpenAlex ID: A5089428201

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

2009 · Jonathan W. Friedberg, Michael D. Taylor, et al. · Journal of Clinical Oncology · 294

VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

2011 · Julie E. Chang, Christopher Peterson, et al. · British Journal of Haematology · 51

VcR-CVAD Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma: A Phase II Study from the Wisconsin Oncology Network

2008 · Brad Kahl, Julie Chang, et al. · Blood · 19

Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL).

2010 · C. Flowers, M. Taylor, et al. · Journal of Clinical Oncology · 2

Works count: 4

Citation count: 366

H-index: 3

I10-index: 3